News

ESMO 2026: Immunotherapy combination extends survival in advanced endometrial cancer

ESMO 2026: New treatment combination shows promising results in recurrent head and neck cancer

Standard kidney function tests underestimate chronic kidney disease in people with cancer

ESMO 2026: Diagnostic test could help doctors refine prostate cancer treatment

ESMO 2026: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancer

Real-world results confirm benefit of PSMA therapy for prostate cancer

Tomosynthesis detects breast cancer more frequently during screening

Scientists discover how cancers evade chemotherapy by entering 'Zombie-like state'

Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study

Six-gene scoring system could help predict leukaemia survival

Study identifies key drivers of microbiome-linked cancer immunotherapy side effect

‘Molecular glue’ stabilises protein that inhibits development of non-small cell lung cancer and uterine cancer